Who
Stephen Hoi Ma
CFO, COO and Secretary
Company insider
Files Form 4 as: CFO, COO and Secretary, Scilex Holding.
In numbers
- Trades disclosed
- 8
- Buys
- 2
- Sells
- 0
- Bought
- $19K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Oct 2023
- Last trade
- 17 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code P | $100K650,000 at $0.1538 | filing |
| 17 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code P | $98K650,000 at $0.15 | filing |
| 8 Oct 2025filed 9 Oct 2025 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 16 Oct 2024filed 17 Oct 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Bought | $6,4996,700 at $0.97 | filing |
| 20 Jun 2024filed 20 Jun 2024 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 20 Jun 2024filed 20 Jun 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Code M | $2,8202,000 at $1.41 | filing |
| 17 May 2024filed 17 May 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Bought | $12K14,140 at $0.88 | filing |
| 4 Oct 2023filed 5 Oct 2023 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
Head-To-Head Contrast: Scilex (NASDAQ:SCLX) versus Eli Lilly and Company (NYSE:LLY)SCLX · themarketsdaily.com · 9 Oct 2026Contrasting Enanta Pharmaceuticals (NASDAQ:ENTA) and Scilex (NASDAQ:SCLX)SCLX · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Stephen Hoi Ma; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.